Ipamorelin
peptideGrowth-hormone secretagogue (ghrelin/GHRP receptor agonist)
Research status · Not FDA-approved
Not FDA-approved for human use. Tested in early research; available (where legal) via compounding. Verify current compounding status.
Ipamorelin is a selective growth-hormone secretagogue often discussed alongside CJC-1295. It is not approved; human data are limited.
How it works
Agonist at the ghrelin/growth-hormone-secretagogue receptor, prompting a pulse of the body's own growth hormone with relatively selective action.
Commonly discussed use cases
- Recovery (discussed)
- Sleep (discussed)
- Body composition (discussed)
Supposed / potential benefits
- Selective GH release with less effect on cortisol/prolactin than older GHRPs (reported)
Common side effects
- Headache
- Flushing
- Increased hunger
- Injection-site reactions
- Water retention
Warnings & contraindications
- Not FDA-approved; long-term safety unknown
- Unregulated sourcing risk
- GH-axis stimulation warrants clinician oversight and labs
Typical timing considerations
Community discussions mention pre-sleep/fasted timing; only a clinician should direct this.
Administration route
Subcutaneous injection
Storage
Refrigerate after reconstitution; follow clinician/pharmacy instructions.
Questions to ask your clinician
- What monitoring do you recommend on the GH axis?
- Any interactions with my current medications?
- What outcome would tell us it's worth continuing?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Sources
Track this in Reta
Beta members get a ready-made tracker for Ipamorelin — schedule, dose log, injection-site rotation, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.